NEW YORK (GenomeWeb News) — Stratos Biosystems said Monday that it has completed pilot production capability for a new protein chip technology that could be used in biomarker-discovery programs for early cancer detection.
Stratos said its EC-Affinity chips for MALDI mass spectrometry are designed to give researchers a high-throughput affinity chromatography tool that is based on a new “self-assembling surface chemistry.”